1. Frontiers in neuroscience Anti-Nogo-A Immunotherapy Does Not Alter Hippocampal Neurogenesis after Stroke in Adult Rats. "A11036 was used in immunohistochemistry - free floating to test if anti-Nogo-A treatment increases hippocampal neurogenesis after stroke" AuthorsShepherd DJ,Tsai SY,O'Brien TE,Farrer RG,Kartje GL 2. eLifeKChIP2 is a core transcriptional regulator of cardiac excitability."A11036 was used in immunocytochemistry to describe a critical role of the ion channel subunit KChIP2 in maintaining electrical stability in cardiac pathology"AuthorsNassal DM,Wan X,Liu H,Maleski D,Ramirez-Navarro A,Moravec CS,Ficker E,Laurita KR,Deschênes I3. OncogeneMUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression."A-11036 was used in immunocytochemistry to investigate the interaction between MUC13 and HER2"AuthorsKhan S,Sikander M,Ebeling MC,Ganju A,Kumari S,Yallapu MM,Hafeez BB,Ise T,Nagata S,Zafar N,Behrman SW,Wan JY,Ghimire HM,Sahay P,Pradhan P,Chauhan SC,Jaggi M4. NatureXRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia."A-11036 was used in immunocytochemistry to investigate the role of XRCC1 protein complexes in normal neurological function and identify PARP1 as a therapeutic target in DNA strand break repair-defective disease"AuthorsHoch NC,Hanzlikova H,Rulten SL,Tétreault M,Komulainen E,Ju L,Hornyak P,Zeng Z,Gittens W,Rey SA,Staras K,Mancini GM,McKinnon PJ,Wang ZQ,Wagner JD,Yoon G,Caldecott KW5. AutophagyUbiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/α-1-antitrypsin Z variant via SQSTM1/p62-dependent selective autophagy."A11036 was used in immunocytochemistry to discover that endoplasmic reticulum membrane-spanning ubiquitin ligase SYVN1/HRD1 enhances the degradation of the Z variant of SERPINA1 through the autophagy-lysosome pathway"AuthorsFeng L,Zhang J,Zhu N,Ding Q,Zhang X,Yu J,Qiang W,Zhang Z,Ma Y,Huang D,Shen Y,Fang S,Yu Y,Wang H,Shen Y |